+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digestive Remedies in Greece

  • PDF Icon

    Report

  • 22 Pages
  • September 2024
  • Region: Greece
  • Euromonitor International
  • ID: 323763
In 2024, digestive remedies in Greece saw the discontinuation of Haleon’s Simeco, one of the key brands in antacids. This resulted in key movements in the competitive landscape, such as an increase in the retail value shares of remaining brands. The leading brands, Maalox Plus (Sanofi-Aventis) and Gaviscon-L (Reckitt Benckiser Hellas) benefited the most from Simeco’s exit.

The Digestive Remedies in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Digestive Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Key withdrawal leads to changes in the competitive landscape of antacids
  • Higher use of probiotics and return to travel norms inform demand trends
  • Price hikes lead to strong retail value growth
PROSPECTS AND OPPORTUNITIES
  • Rise in anxiety and stress levels create growth potential
  • Changes in diet and nutrition habits to hamper need for digestive remedies
  • Delivery formats to drive development
CATEGORY DATA
  • Table 1 Sales of Digestive Remedies by Category: Value 2019-2024
  • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Digestive Remedies: % Value 2020-2024
  • Table 4 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
  • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
  • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN GREECE
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources